UniProtKB/Swiss-Prot Q05066: Variant p.Lys106Ile

Sex-determining region Y protein
Gene: SRY
Chromosomal location: Yp11.3
Variant information

Variant position:  106
The position of the amino-acid change on the UniProtKB canonical protein sequence.

Type of variant:  Disease [Disclaimer]
The variants are classified into three categories: Disease, Polymorphism and Unclassified.
  • Disease: Variants have been found in patients and disease-association is reported in literature. However, this classification is not a definitive assessment of variant pathogenicity.
  • Polymorphism: No disease-association has been reported.
  • Unclassified: Variants have been found in patients but disease-association remains unclear.

Residue change:  From Lysine (K) to Isoleucine (I) at position 106 (K106I, p.Lys106Ile).
Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.

Physico-chemical properties:  Change from large size and basic (K) to medium size and hydrophobic (I)
The physico-chemical property of the reference and variant residues and the change implicated.

BLOSUM score:  -3
The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:
  • Lowest score: -4 (low probability of substitution).
  • Highest score: 11 (high probability of substitution).
More information can be found on the following page

Variant description:  In SRXY1.
Any additional useful information about the variant.



Sequence information

Variant position:  106
The position of the amino-acid change on the UniProtKB canonical protein sequence.

Protein sequence length:  204
The length of the canonical sequence.

Location on the sequence:   RNSEISKQLGYQWKMLTEAE  K WPFFQEAQKLQAMHREKYPN
The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.

Residue conservation: 
The multiple alignment of the region surrounding the variant against various orthologous sequences.

Human                         RNSEISKQLGYQWKMLTEAEKWPFFQEAQKLQAMHREKYPN

Gorilla                       RNSEISKQLGYQWKMLTEAEKWPFFQEAQKLQAMHREKYPN

Rhesus macaque                RNSEISKQLGYQWKMLTEADKWPFFQEAQKLQAMHREKYPN

Chimpanzee                    RNSEISKQLGYQWKMLTEAEKWPFFQEAQKLQAMHREKYPN

Mouse                         QNTEISKQLGCRWKSLTEAEKRPFFQEAQRLKILHREKYPN

Pig                           QNSEISKWLGCKWKMLTEAEKRPFFEEAQRLQAVHRDKYPG

Bovine                        KNSDISKQLGYEWKRLTDAEKRPFFEEAQRLLAIHRDKYPG

Goat                          QNSEISKQLGYEWKRLTDAEKRPFFEEAQRLLAIHRDKYPG

Sheep                         QNSEISKQLGYEWKRLTDAEKRPFFEEAQRLLAIHRDKYPG

Cat                           QNSEISKQLGYQWKMLTQAEKWPFFEEAQRLQALHREKYPG

Dog                           QNSEISKQLGYQWKMLTEAEKWPFFEEAQRLQAMHREKYPD

Horse                         QNSEISKRLGCQWKMLTEAEKLPFFEEAQRLRAMHQEKYPD

Sequence annotation in neighborhood:  
The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
  • Type: the type of sequence feature.
  • Positions: endpoints of the sequence feature.
  • Description: contains additional information about the feature.

TypePositionsDescription
Chain 1 – 204 Sex-determining region Y protein
DNA binding 60 – 128 HMG box
Region 59 – 136 Sufficient for interaction with KPNB1
Mutagenesis 115 – 115 K -> R. Does not abolish acetylation activity.
Mutagenesis 123 – 123 K -> R. Does not abolish acetylation.
Helix 103 – 123


Literature citations

Evidence for increased prevalence of SRY mutations in XY females with complete rather than partial gonadal dysgenesis.
Hawkins J.R.; Taylor A.; Goodfellow P.N.; Migeon C.J.; Smith K.D.; Berkovitz G.D.;
Am. J. Hum. Genet. 51:979-984(1992)
Cited for: VARIANTS SRXY1 MET-90 AND ILE-106;

Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.